AdvisorShares, a leading sponsor of actively managed exchange traded funds (ETFs), today announced the launch of the AdvisorShares Psychedelics ETF . PSIL invests in the emerging psychedelic drugs sector, offering exposure to biotechnology, pharmaceutical, and life sciences companies leading the way in this nascent industry.